GlassScriptPhysician profile
Elizabeth P Aaron
NPI 1174187967
$2,565.50
in general payments reported to CMS, 2019-2025
30 companies · $734 in 2025
The $734 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.66 · 2022: $310 · 2023: $597 · 2024: $905 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,236.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $339.63 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $243.34 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $183.64 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $181.56 | 2023-2024 | |
| Amgen INC. | $180.37 | 2023-2025 | Evenity, Prolia, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.00 | 2022-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $134.87 | 2024-2025 | |
| Abbvie INC. | $134.38 | 2023-2025 | Vraylar, Ubrelvy, Synthroid |
| Astellas Pharma US INC | $123.82 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $122.26 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $96.98 | 2022-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $87.47 | 2022-2024 | Farxiga |
| Sumitomo Pharma America, INC. | $60.34 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $53.63 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.63 | 2024 | Jardiance |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $38.70 | 2025 | |
| Esperion Therapeutics, INC. | $38.44 | 2024-2025 | Nexletol |
| Merck Sharp & Dohme LLC | $35.98 | 2023-2024 | Gardasil, Gardasil 9, Vaqta |
| Abbott Laboratories | $35.75 | 2023-2025 | Freestyle Libre 3 |
| Gilead Sciences, INC. | $34.93 | 2025 | |
| Corium, LLC | $33.56 | 2023 | Adlarity |
| Boston Scientific Corporation | $33.07 | 2021-2023 | Tactra |
| Dynavax Technologies Corporation | $26.52 | 2025 | Heplisav-B |
| Shield Therapeutics INC | $23.09 | 2023 | Accrufer |
| Calliditas Therapeutics US INC. | $22.10 | 2025 | Tarpeyo |
| Antares Pharma, INC. | $21.81 | 2022 | |
| Xeris Pharmaceuticals, INC. | $21.55 | 2023 | Gvoke Hypopen |
| Inspire Medical Systems, INC. | $21.38 | 2025 | Inspire |
| Biogen, INC. | $19.93 | 2025 | Leqembi |
| Ibsa Pharma INC. | $18.77 | 2024 | Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Aaron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.